Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal estriol cream after radiotherapy for cervical cancer
RBR-3j3mkjtCompleted
- Sponsor
- IMIP
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Cervical Cancer (CC) comparing Estriol vaginal cream with Placebo (2 arms). Primary endpoint: Change in vaginal epithelial histological grade. Started May 2024; status: completed.
02
Drugs
estriol
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on RBR-3j3mkjt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3j3mkjt.